Prescription Format in India: NMC Rules and Sample Layout
Review NMC prescription provisions, an annotated OPD format, a two-doctor document audit and reprint checks that preserve the original issued copy.
For a supply covered by Rule 65(3)(h) of India’s Drugs Rules, Schedule H1 recording happens at the time of supply in a separate register. The provision names the prescriber and address, patient, drug and quantity supplied, with records maintained for three years and available for inspection. First establish the clinic’s dispensing and licensing context; prescribing, dispensing and maintaining a patient record are different activities.
Indian clinic owners, prescribing doctors and appropriately authorized dispensary personnel clarifying Schedule H1 records and catalogue updates.
A doctor may prescribe a medicine that the patient purchases from an independent pharmacy. In another setting, an authorized dispensary associated with the clinic may supply it. Those arrangements involve different records and responsibilities. A prescription draft is evidence of an intended order; it is not evidence that a quantity was handed to the patient.
Before configuring a register, document who supplies medicines, under what applicable licence or other lawful basis, and who is responsible for the records. Do not assume that owning an EMR, employing a doctor or printing a receipt establishes permission to operate a retail pharmacy. Confirm the actual arrangement with the relevant licensing authority or an appropriately qualified adviser.
This distinction also prevents a common software error: generating dispensing entries from every prescription, including unfilled and cancelled orders. Connect the register to a verified supply event within the applicable process. If the clinic only prescribes, its clinical record still needs to identify what the doctor ordered, but an external pharmacy’s supply should not be fabricated.
The CDSCO compilation of the Drugs Rules contains the separate-register provision for Schedule H1 supply. Its listed particulars are the prescriber’s name and address, the patient’s name, the drug’s name and the quantity supplied. Recording is at the time of supply; the records are to be maintained for three years and remain open for inspection.
The table separates those particulars from additional operational fields proposed here. A timestamp, internal supply identifier or batch link can help reconstruct an event, but should not be misrepresented as wording taken from that sub-rule. Other applicable provisions and licence conditions may add requirements.
On a narrow screen, scroll the table horizontally to read all columns.
| Element | Basis | Practical recording decision |
|---|---|---|
| Prescriber name and address | Named in Rule 65(3)(h) | Retain the relevant details with the supply record |
| Patient name | Named in Rule 65(3)(h) | Link to the correct patient; a shared family phone is not sufficient identity |
| Drug name and quantity supplied | Named in Rule 65(3)(h) | Record actual supply with an unambiguous quantity unit |
| Time, supply identifier and prescription link | Additional workflow proposal here | Connect the event to the order without treating ordered quantity as supplied quantity |
| Batch, operator and amendment history | Additional traceability proposal here | Support investigation and transparent corrections within the clinic’s applicable obligations |
Source: CDSCO: Drugs Rules, 1945, consolidated through July 2024
Schedule H1 should not be treated as a permanent list copied once into a spreadsheet. Nor is it simply a synonym for all antibiotics. A classification decision needs the current applicable schedule, relevant amendments and their commencement provisions. The official Gazette register contains both drafts and final notifications; their legal stages are different.
Pregabalin illustrates the distinction. The January 2026 G.S.R. 54(E) document was a draft. The later final G.S.R. 377(E), dated 13 May 2026 and appearing in the Gazette dated 20 May 2026, provides for adding pregabalin to Schedule H1 after 180 days from publication. As of this guide’s check on 28 October 2026, that period has not elapsed. This is a future-commencement amendment at that checkpoint, not evidence that the addition is already operative.
That observation concerns this amendment’s commencement only; it does not imply unrestricted sale or resolve other requirements for the medicine. Before applying a rule to an actual transaction, verify the current official text and any later change. Keep the document, publication date, commencement rule and person who approved the catalogue update together.
Source: Gazette of India: G.S.R. 377(E), Drugs (Second Amendment) Rules, 2026
The CDSCO listing checked for this pass also labels G.S.R. 745(E), dated 19 August 2026, as a draft concerning four additional H1 drugs. That listing is a discovery aid, not the full operative text. It does not establish that a later final notification is absent. Before changing a live classification, retrieve the applicable instrument and resolve its status and commencement with the person responsible for the clinic’s legal arrangement.
A catalogue can have a pending change without treating it as effective for every earlier transaction. Give pending changes an owner and an explicit review trigger. If the software cannot represent future commencement, document the controlled manual update needed at the appropriate time; do not change historic records in advance merely because a final notification has been uploaded.
This status table is deliberately limited to the documents cited here. It is not a complete current H1 list. It demonstrates what staff should preserve when a news headline, a supplier message and a Gazette document appear to disagree: the exact instrument, its stage and the unresolved decision.
On a narrow screen, scroll the table horizontally to read all columns.
| Instrument | Evidence inspected | Status supported by that evidence | Catalogue decision |
|---|---|---|---|
| G.S.R. 54(E), 21 January 2026 | Its draft history is described in the final G.S.R. 377(E) | Earlier proposal; use the final instrument for the resulting amendment | Do not treat the January proposal date as commencement |
| G.S.R. 377(E), 13 May 2026 | Final Gazette text dated 20 May; 180-day commencement clause | Final amendment with the stated period not elapsed on 28 October | Retain publication and commencement evidence; recheck before applying to a transaction |
| G.S.R. 745(E), 19 August 2026 | CDSCO notification-index entry | Listed as a draft; full text and any later final instrument need checking | Do not activate proposed additions from the listing alone |
Source: Gazette of India: G.S.R. 377(E), Drugs (Second Amendment) Rules, 2026
Consider a fictional prescription for 12 units of an H1-classified item. The authorized dispensary supplies 8 units on one occasion and 4 later, where the later supply is permitted under the applicable prescription and rules. The operational history contains two supply events totalling 12 units. Copying “12” from the prescription into each event would falsely record 24.
Record the quantity and unit at each actual handover, with a link to the prescription and earlier event. Preserve the difference between a planned balance and a completed later supply. The pending balance is not a reason to assume that the patient returned or that a second supply was legally permitted.
A prescription cancelled before any medicine leaves the dispensary should not appear as completed supply. A return after supply is different again: retain the original event and record the return and disposition separately. Do not erase the first entry to make the inventory and register look simpler.
Expand the 12-unit example into a fictional evidence ledger. Assume both supplies have first been established as permitted under the applicable prescription and lawful supply arrangement. The item is an invented H1-classified tablet for recordkeeping practice; the quantities are not a recommended course. Every true supply retains the required particulars. The references and other event links below are additional operational suggestions.
The two actual supplies total 8 + 4 = 12 tablets. Importing the first paper entry after an outage is a representation of the same eight-tablet event, not a third handover. If that import is counted again, the apparent supplied total becomes 20. If two tablets are later returned, gross supplied remains 12 and separately recorded returns are 2. The net outward movement is 10, which says nothing about doses taken or the patient’s current remaining tablets.
A return should not automatically become available stock. Keep the return’s identity, condition and disposition within the authorized process, including any quarantine decision. Similarly, a correction to a quantity description is not another stock movement. Separating these events allows clinical, supply and inventory reviewers to answer their own questions without rewriting the original supply to make one total convenient.
On a narrow screen, scroll the table horizontally to read all columns.
| Reference and event | Quantity represented | Supporting evidence | How to count and preserve it |
|---|---|---|---|
| H-201 — first actual supply | 8 tablets supplied | Contemporaneous paper entry P-17 and relevant prescription | Count 8 once; retain particulars and original source |
| H-202 — later permitted supply | 4 tablets supplied | New handover evidence linked to the prescription and H-201 | Count 4 once; remaining planned quantity alone would not establish supply |
| B-201 — digital backfill of P-17 | Same 8 tablets as H-201 | Source reference P-17; recorded entry and import times | Count no additional supply; link the two representations |
| R-201 — return linked to H-201 | 2 tablets returned | Separate receipt and disposition record | Show returns separately; do not replace H-201 with 6 |
| C-201 — quantity-unit clarification | 8 unspecified units clarified as 8 tablets | Original entry plus verified source and reason for amendment | Retain old and corrected wording; no new physical movement |
A clinic should agree its fallback recording arrangement before an outage and verify that arrangement against the relevant authority’s expectations. Later data entry cannot retroactively make a missing contemporaneous record complete. Staff should preserve the actual source and escalate omissions transparently rather than invent a supply time or backdate an entry to appear compliant.
For fictional H-201, the supply was recorded on paper at 10:05 and transcribed after service returned at 12:20. Keep both times with their meanings. If two staff members import P-17, the source reference should reveal that they are reconciling one event. A match on patient name and drug alone is insufficient: the same person could have another valid supply, and two patients can share a name.
The completed handover below records a hypothetical problem found during reconciliation. It is not a prescribed statutory form. The second person checks the paper source, the visible digital particulars and the export. Mark the issue unresolved if source evidence cannot establish the unit; a supervisor’s click is not evidence that eight unspecified units were tablets.
Do not infer format acceptance from a vendor’s “H1 compliant” label. Establish the relevant authority’s expectations for the clinic’s specific arrangement, including availability for inspection, the particulars recorded, retention, corrections and the ability to produce usable records. The cited sub-rule alone is not a product certification.
Try an inspection-style retrieval with fictional data: choose a date range, identify the relevant supply, see the particulars and follow the link to its source. Repeat after an amendment and from an export. A screen that only shows current values may omit the evidence needed to explain a corrected quantity.
For retention planning, keep this supply-register requirement separate from the retention policy for clinical notes, prescriptions, inventory records and backups. A three-year provision for one record category does not authorize automatic deletion of all OPD records at three years.
A full register is not necessarily an accurate register. Sample an actual supply against its source, inspect entries with missing prescriber details and compare partial supplies with the quantities recorded. Include cancelled prescriptions, returned stock and later corrections in the review so the normal path does not hide exception errors.
For a fictional review of 20 supply events, suppose 18 can be reconstructed and two have unclear quantity units. Report two unresolved events out of 20, identify their owners and repair them transparently from evidence. Do not report “100% compliant” just because all 20 rows contain some text.
Treat a rule update as a controlled change with an effective date. Brief the responsible staff, check catalogue flags and preserve what was applied to earlier events. Rewriting historical classifications without explanation can obscure whether the clinic acted under the rule in force at the time.
Choose H-201 in a fictional date-range export. Can a reader identify the actual medicine and quantity, the required prescriber and patient particulars, the source record, and the explanation for C-201? Open the export away from the live screen. A link that only works for the original operator may be inadequate for the clinic’s inspection or continuity process. Confirm the actual accepted access and format requirements rather than assuming that a PDF or spreadsheet is sufficient.
Next inspect totals. The export should distinguish two supply events from a backfill, a return and a correction. Check whether filtering by entry time accidentally omits a supply recorded on paper earlier, or whether selecting the supply date hides a subsequent amendment. Decide how both views will be explained. The additional time fields help this reconciliation; they are not a substitute for the particulars named in the cited provision.
Keep a compact exception list: event reference, missing evidence, responsible person, next action and closure evidence. Avoid copying an entire register into email or a messaging group merely to resolve one unit mismatch. Use the clinic’s controlled access route for patient-linked records. A vendor demonstration should use fictional particulars and should show both successful retrieval and an intentionally unresolved entry.
A fictional authorized dispensary supplies 8 units and later 4 units against a 12-unit prescription, after verifying that the later supply is permitted. Each event records its own actual quantity and source link. During review, staff can distinguish the first supply, the pending balance and the completed second supply. The prescription is not used as a shortcut to manufacture either event.
Use these prompts in your clinic’s own notes. Record the result, responsible person and next action for each item.
No. A transcription of the same event should link to its original source and retain supply time and later entry time separately. Count the actual handover once. Verify the clinic’s fallback and electronic-record arrangement against applicable requirements.
Preserve the original supply and record the return and disposition separately. In the fictional example, 12 supplied and 2 returned remain distinct facts; net outward movement of 10 does not show what the patient consumed or what stock may be reused.
No. Do not classify a medicine solely by calling it an antibiotic or another broad category. Check the applicable schedule and amendments, including commencement dates.
It names the prescriber and address, patient, drug and quantity supplied. The entry is made at supply, with the records maintained for three years and available for inspection, subject to the provision’s applicable context.
The cited final G.S.R. 377(E) specifies commencement after 180 days from Gazette publication in May 2026. That period has not elapsed at the guide’s 28 October checkpoint. Recheck the official position for an actual transaction; this does not establish that other restrictions are absent.
No. Applicable authority, actual supply records, staff responsibilities, current classification, format acceptance and inspection access must be established. A software label cannot settle those questions.
No. It concerns the cited supply records. Clinical notes, other dispensing records and related material need a retention schedule based on their own applicable requirements and circumstances.
Updated on . Cited rule text, the pregabalin notification and the CDSCO Gazette listing checked on 28 October 2026. This guide distinguishes published provisions from original recording examples; it is not a complete legal search or a determination of a particular clinic’s licence, exemption or permitted dispensing activity. No independent clinical or legal review is claimed.
Rule 65(3)(h), PDF page 44, checked 28 October 2026. The compilation is a base text, not a substitute for later amendments or applicable licence conditions. The fictional event ledger and correction procedure are original operational proposals.
Final two-page notification checked 28 October 2026, including its account of the earlier draft, Gazette date and 180-day commencement provision. The checkpoint statement concerns this instrument, not every restriction or later transaction.
Official discovery listing checked 28 October 2026; G.S.R. 745(E) appears as a draft. That index entry is not a review of its full text or proof that no later final instrument exists. Draft, final and commencement stages remain distinct.
Review NMC prescription provisions, an annotated OPD format, a two-doctor document audit and reprint checks that preserve the original issued copy.
Reconcile medicine batches with worked pack conversions, split supplies, reservations, quarantine and returns for Indian clinic dispensaries.
Build a shared clinic formulary using a worked intake review, change-impact ledger and handover for favourites, saved sets, drafts and issued prescriptions.
Build a clinic retention schedule with scoped NMC guidance, a worked date review, hold instructions and an archive retrieval test before EMR exit.
Bring a fictional partial-supply example and the format confirmed for your dispensing arrangement to discuss register particulars, event history and retrieval in the available workflow.
Request a clinic demo